<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>96</volume><submitter>Dong SJ</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The presence of left atrial/left atrial appendage thrombosis is associated with a higher risk of thromboembolic events in patients with atrial fibrillation. The optimal antithrombotic strategy is not established to date.&lt;h4>Objective&lt;/h4>Our aim was to compare the efficacy and safety profile of novel oral anticoagulants with warfarin in the treatment of left atrial/left atrial appendage thrombosis.&lt;h4>Methods&lt;/h4>We conducted a systematic search in PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and 3 Chinese databases for all randomized controlled trials and cohort studies (PROSPERO, CRD42021238952) from inception to 7 May 2021. Two authors independently performed the articles selection, data extraction, and quality assessment. The efficacy outcome was the resolut</pubmed_abstract><journal>Current therapeutic research, clinical and experimental</journal><pagination>100670</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9062445</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy and Safety Profile of Novel Oral Anticoagulants in the Treatment of Left Atrial Thrombosis: A Systematic Review and Meta-Analysis.</pubmed_title><pmcid>PMC9062445</pmcid><pubmed_authors>Xiao CL</pubmed_authors><pubmed_authors>Luo CY</pubmed_authors><pubmed_authors>Zhai SD</pubmed_authors><pubmed_authors>Han ZL</pubmed_authors><pubmed_authors>Dong SJ</pubmed_authors><pubmed_authors>Zhang FZ</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy and Safety Profile of Novel Oral Anticoagulants in the Treatment of Left Atrial Thrombosis: A Systematic Review and Meta-Analysis.</name><description>&lt;h4>Background&lt;/h4>The presence of left atrial/left atrial appendage thrombosis is associated with a higher risk of thromboembolic events in patients with atrial fibrillation. The optimal antithrombotic strategy is not established to date.&lt;h4>Objective&lt;/h4>Our aim was to compare the efficacy and safety profile of novel oral anticoagulants with warfarin in the treatment of left atrial/left atrial appendage thrombosis.&lt;h4>Methods&lt;/h4>We conducted a systematic search in PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and 3 Chinese databases for all randomized controlled trials and cohort studies (PROSPERO, CRD42021238952) from inception to 7 May 2021. Two authors independently performed the articles selection, data extraction, and quality assessment. The efficacy outcome was the resolut</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-07-14T14:41:26.549Z</modification><creation>2024-11-15T12:41:12.241Z</creation></dates><accession>S-EPMC9062445</accession><cross_references><pubmed>35515958</pubmed><doi>10.1016/j.curtheres.2022.100670</doi></cross_references></HashMap>